Biotech

Category / Pharmaceuticals & Biotech / Biotech

MethylGene Presents MGCD265 Data at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

Immunovaccine's DPX-0907 Demonstrates Ability to Generate Promising Immune Reponses in Multiple Cancers in a Clinical Trial Presented at ASCO Annual Meeting

HALIFAX, NOVA SCOTIA: Targeted Immunotherapy Shows Safety While Triggering Multi-Functional T Cell Responses in Cancer Patients ...

Theratechnologies Inc.: Tesamorelin Filed for Marketing Approval in Colombia and Venezuela

MONTREAL, CANADA: ...

Xcovery Presents Phase 1 Clinical Results at ASCO Annual Meeting

WEST PALM BEACH, FL and CHICAGO, IL: Study Is First-in-Human Trial of an Oral VEGFR Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Solid Tumors ...

Paladin Labs Inc.: Travelan(R) Market Approval Application Accepted for Review by Health Canada

MONTREAL, CANADA and MELBOURNE, AUSTRALIA: ...

Cellceutix CEO, and Advisor Jim Boeheim Interviewed by Boston Herald About New Cancer Drug; Company Provides Update on p53 Compounds From Annual ASCO Meeting

BEVERLY, MA: ...

Cees Heiman Joins The Medicines Company to Lead Europe and Middle East Business

ZURICH, SWITZERLAND: Experienced Global Executive Joins to Drive Regional Growth, Contribute to Global Strategy in Acute and Intensive Care Hospital Medicine ...

Medivation and Astellas Announce Enzalutamide Data Relating to Quality of Life Measures and Extension of Time to First Skeletal-Related Event

SAN FRANCISCO, CA and TOKYO: New Data From Phase 3 AFFIRM Trial Presented at ASCO ...

West Announces Purchase Price for Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047

LIONVILLE, PA: ...

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

BOTHELL, WA: ...

Marina Biotech Ceases Most Day-to-Day Operations

BOTHELL, WA: Continues to Seek Substantial Funding and Strategic Opportunities ...

GLG Life Tech Corporation Announces Change in Auditor and Intention to Delist From NASDAQ

VANCOUVER, BRITISH COLUMBIA: ...

Genelux Corporation Announces Treatment of First Patient in Phase I/II Clinical Trial of GL-ONC1 in Advanced Peritoneal Cavity Cancers

SAN DIEGO, CA: Study Marks First Time Cancer Patients Are Treated With Oncolytic Vaccinia Virus in Germany ...

Biotonix Announces First Quarter 2012 Results

BROSSARD, QUEBEC: ...

Paladin Labs to Present at the Jefferies Global Healthcare Conference in New York

MONTREAL, QUEBEC: ...

Single Center Data From C-Pulse(R) Feasibility Trial in Patients With Moderate to Severe Heart Failure to Be Presented at the 2012 ISMICS Annual Meeting

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: Findings From Single Center Highlight Minimally Invasive Thoracotomy Implantation Technique of Novel Counter-Pulsation Cardiac Device ...

Biocompare's Antibody Search Tool Is Now Available on the iPad

SOUTH SAN FRANCISCO, CA: ...

Med Biogene Reports Financial Results for Q1 2012